DSpace Repository

Personalized Medicine Perspectives and Policies in European Nordic Countries

Show simple item record

dc.contributor.author GARABAJIU, Maria
dc.contributor.author GALEA-ABDUSA, Daniela
dc.contributor.author TOPA, Alexandra
dc.contributor.author GUSILA, Ilenuta
dc.contributor.author CUROCICHIN, Ghenadie
dc.date.accessioned 2023-11-16T11:07:37Z
dc.date.available 2023-11-16T11:07:37Z
dc.date.issued 2023
dc.identifier.citation GARABAJIU, Maria, GALEA-ABDUSA, Daniela, TOPA, Alexandra et al. Personalized Medicine Perspectives and Policies in European Nordic Countries. In: 6th International Conference on Nanotechnologies and Biomedical Engineering: proc. of ICNBME-2023, 20–23, 2023, Chisinau, vol. 2: Biomedical Engineering and New Technologies for Diagnosis, Treatment, and Rehabilitation, 2023, p. 471-479. ISBN 978-3-031-42781-7. e-ISBN 978-3-031-42782-4. en_US
dc.identifier.isbn 978-3-031-42781-7
dc.identifier.isbn 978-3-031-42782-4
dc.identifier.uri https://doi.org/10.1007/978-3-031-42782-4_50
dc.identifier.uri http://repository.utm.md/handle/5014/24863
dc.description Acces full text - https://doi.org/10.1007/978-3-031-42782-4_50 en_US
dc.description.abstract The technical revolution has generated large numbers of data in healthcare and biomedical research. Thus, research and innovation became a growing priority to support a change from the one-size-fits-all paradigm of healthcare to Personalized medicine, also called precision medicine. This important pillar in realizing innovation priority in healthcare - Personalized Medicine started its moving fast forward all over the word for the last decade. The aims of PM are to solve health problems by enabling early, individualized diagnosis and treatment, using characterization of individuals’ phenotypes and genotypes. The Nordic region, comprising primarily Denmark, Estonia, Finland, Iceland, Norway and Sweden, has many of the necessary characteristics for being at the forefront of genome-based Personalized Medicine development and implementation into clinical care. Remarkably, Nordic countries were the first European countries that started developing Biobank and legislation in this direction. The Joint Committee of the Nordic Medical Research Councils is a cooperative body responsible for the medical research councils of the Nordic countries, which has straightened strategies towards personalized medicine since 2011 and reaching very good result in implementation of this concept, before other European countries. All Nordic countries directed national strategies either specifically towards personalized medicine or to closely related areas, advancing infrastructure development. The most important pitfall in this region is the reliable genetic basis, which started its evolution in early 90-th by implementation of Genome Projects. Nowadays, Nordic countries show perfect example of Personalized Medicine implementation and continuous development, overcoming hurdles and setting ambitious goals. en_US
dc.language.iso en en_US
dc.publisher Springer Nature Switzerland en_US
dc.rights Attribution-NonCommercial-NoDerivs 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.subject nordic countries en_US
dc.subject personalized medicine en_US
dc.subject precision medicine en_US
dc.title Personalized Medicine Perspectives and Policies in European Nordic Countries en_US
dc.type Article en_US


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

  • 2023
    6th International Conference on Nanotechnologies and Biomedical Engineering, September 20–23, 2023, Chisinau, Moldova

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States

Search DSpace


Advanced Search

Browse

My Account